The viability of the breast cancer cell line MCF-7 and MDA-MB-231 upon exposure of siRNA targeting three anti-apoptotic genes, namely, Mcl-1, Bcl-2, and survivin, was examined by MTT assay. This evidence concerns the gene BCL2 and breast carcinoma.